Recent IPO Companies
Explore all recent IPO filings with AI-powered analysis. Stay informed about companies going public.
📊
45 Companies
🤖
AI Analyzed
Last Year
HawkEye 360, Inc.
HAWK
$416.0M
May 7
Highlights
- Unique 'radio detective' satellite technology that tracks targets even without G...
- Rapid revenue growth, more than doubling year-over-year in Q1 2026
View Analysis
🤖 AI
Rare Earths Americas, Inc.
REA
$63.3M
May 7
Highlights
- Targets high-demand 'ionic clay-hosted' rare earth deposits
- Strategic exploration projects located in Georgia and Brazil
View Analysis
🤖 AI
Rush Street Interactive, Inc.
RSI
$260.0M
May 6
Highlights
- Proprietary technology stack reduces reliance on third-party providers
- Strong market presence across 16 U.S. states and multiple international regions
View Analysis
🤖 AI
Picard Medical, Inc.
PMI
$5.0M
May 6
Highlights
- Owns SynCardia, the only FDA-approved Total Artificial Heart (TAH) in the U.S. a...
- Proven life-saving technology utilized in over 2,100 patients worldwide.
View Analysis
🤖 AI
Seaport Therapeutics, Inc.
SPTX
$254.9M
May 1
Highlights
- Proprietary 'Glyph' platform bypasses the liver to improve drug delivery to the ...
- Leadership team includes co-founders of Karuna Therapeutics, which achieved a $1...
View Analysis
🤖 AI
SILVER BOW MINING CORP.
SBMT
$59.8M
May 1
Highlights
- Strategic land position in Butte, Montana, including the 878-acre 'Rainbow Block...
- Utilizes advanced AI-driven geological modeling to identify mineral deposits.
View Analysis
🤖 AI
Hemab Therapeutics Holdings, Inc.
COAG
$301.5M
May 1
Highlights
- Focus on high-unmet-need rare blood-clotting disorders
- Advanced pipeline featuring Sutacimig (HMB-001) in clinical trials
View Analysis
🤖 AI
Avalyn Pharma Inc.
AVLN
$300.0M
April 30
Highlights
- Innovative drug-device combination targeting rare respiratory diseases
- Proprietary high-efficiency nebulizer technology improves drug delivery
View Analysis
🤖 AI
Veradermics, Inc
MANE
$384.4M
April 30
Highlights
- Developing VDPHL01, a potential first-to-market oral minoxidil for female hair l...
- Successful Phase 3 clinical trial results with 519 participants showing signific...
View Analysis
🤖 AI
SYNTEC OPTICS HOLDINGS, INC.
OPTX
$20.0M
April 30
Highlights
- Specialized manufacturer of high-precision optical components for defense, medic...
- Critical supplier for advanced technology, including night-vision goggles, satel...
View Analysis
🤖 AI
Pershing Square USA, Ltd.
PSUS
$2.0B
April 30
Highlights
- No performance fees charged to investors
- Weekly transparency on fund holdings
View Analysis
🤖 AI
PERSHING SQUARE INC.
PS
0
April 30
Highlights
- Access to institutional-grade investment management for retail investors
- Permanent capital model allows for long-term, patient investment strategies
View Analysis
🤖 AI
Stay Ahead of the Market
Get AI-powered insights on every IPO filing. Our advanced algorithms analyze complex SEC documents to bring you the key information that matters.
Back to Homepage